There has been knowledge stating that hypermethylation of the CDKN2A gene can induce erosion of CDKN2A expression in many malignancies, involving hepatocellular carcinoma [24], cervical cancer [25], and non-small cell lung cancer [26]. The gene discussed is CDKN2A; the disease is cervical carcinoma.